Insulin Patch Pumps

  • November 2011
  • -
  • Greystone Research Associates

The collapse of the inhaled insulin market in 2008 has resulted in programs focused on alternative insulin delivery technologies. It now appears that the patch pump – a device that represents the convergence of a transdermal reservoir system with an energy source and control technology – will be the next generation in the evolution in patient-friendly insulin administration. With four FDA-approved insulin patch pump products and twice as many serious development-stage devices, the next 36 months will be critical to market sector participants wishing to ascend to a leadership position in the market segment. With no room for post-market missteps, product reliability, ease-of-use and patient acceptance will be essential for market success.

Highlights

• Analyzes and evaluates insulin patch pump products and development-stage candidates and assesses risks and market potential
• Analyzes insulin patch pump product strategies, technologies and patch development issues
• Provides assessments of insulin patch pump products
• Provides market data and forecasts to 2015
• Profiles market sector participants, their product development activities and business strategies

Table Of Contents

Summary of Contents
Executive Summary

Diabetes Market Dynamics

Shifting Insulin Delivery Markets
Demand Drivers
Demographic Shifts
Managed Care Initiatives
Growth in Home Healthcare
Technology Market Drivers
Competitive Landscape

Patch Pump Device Strategies

Device/System Architecture
Drug Delivery Mechanism
Drug Reservoirs
Sized Patch Pumps
Handheld Remote Electronics
Accuracy and Dosing Variability
Alerts and Patient Notification
Special Features

FDA-Approved Insulin Patch Pumps - Analysis and Market Data

Finesse
OmniPod
Solo
V-Go

Development-Stage Insulin Patch Pumps - Assessments and Forecasts

Cellnovo
CeQur
Freehand
Jewel Pump
Medipacs
PassPort
Sensile Medical
Spring Hybrid Pump
SteadyMed

Market Factors
Regulations
U.S.
International
Trials and Approval
IP and Product Positioning

Sector Participant Company Profiles

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The prostate cancer pipeline is among the largest in the ...

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in Parkinson's Disease Pipeline The Parkinson's disease (PD) pipeline ...

Biological Therapies for Cancer: Technologies and Global Markets

Biological Therapies for Cancer: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.